dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Gulley, James L. |
dc.contributor.author | Borre, Michael |
dc.contributor.author | Vogelzang, Nicholas J. |
dc.contributor.author | Ng, Siobhan |
dc.contributor.author | Parker, Chris C. |
dc.contributor.author | Carles Galceran, Joan |
dc.contributor.author | Agarwal, Neeraj |
dc.date.accessioned | 2021-03-11T14:25:03Z |
dc.date.available | 2021-03-11T14:25:03Z |
dc.date.issued | 2019-05-01 |
dc.identifier.citation | Gulley JL, Borre M, Vogelzang NJ, Ng S, Agarwal N, Parker CC, et al. Phase III Trial of PROSTVAC in asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer. J Clin Oncol. 2019;37(13):1051–61. |
dc.identifier.issn | 1527-7755 |
dc.identifier.uri | https://hdl.handle.net/11351/5751 |
dc.description | Prostate cancer; Metastatic neoplasm; Immunotherapy |
dc.language.iso | eng |
dc.publisher | American Society of Clinical Oncology |
dc.relation.ispartofseries | Journal of Clinical Oncology;37(13) |
dc.rights | Attribution 4.0 International |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pròstata - Càncer - Tractament |
dc.subject | Vacunes contra el càncer |
dc.subject | Metàstasi |
dc.subject.mesh | Prostatic Neoplasms, Castration-Resistant |
dc.subject.mesh | Neoplasm Metastasis |
dc.subject.mesh | Cancer Vaccines |
dc.title | Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1200/JCO.18.02031 |
dc.subject.decs | neoplasias prostáticas resistentes a la castración |
dc.subject.decs | metástasis neoplásica |
dc.subject.decs | vacunas del cáncer |
dc.relation.publishversion | https://ascopubs.org/doi/10.1200/JCO.18.02031 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Gulley JL] National Institutes of Health, Bethesda, MD. [Borre M] Aarhus Universitetshospital, Åarhus, Denmark. [Vogelzang NJ] Comprehensive Cancer Centers of Nevada, Las Vegas, NV. [Ng S] St John of God Subiaco Hospital, Subiaco, Western Australia, Australia. [Agarwal N] University of Utah Huntsman Cancer Institute, Salt Lake City, UT. [Carles J] Genitourinary, CNS and Sarcoma Tumors Program, Vall d’Hebron Institute of Oncology, Barcelona, Spain. Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 30817251 |
dc.identifier.wos | 000468265100005 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |